Cite

HARVARD Citation

    Cengiz Seval, G. et al. (2019). A comparative safety review of histone deacetylase inhibitors for the treatment of myeloma. Expert opinion on drug safety. 18 (7), pp. 563-571. [Online]. 
  
Back to record